Volume 134, Issue 1, Pages (January 2008)

Slides:



Advertisements
Similar presentations
Volume 130, Issue 2, Pages (February 2006)
Advertisements

Volume 132, Issue 1, Pages (January 2007)
In Situ Expression of Interleukin-10 in Noninflamed Human Gut and in Inflammatory Bowel Disease  Frank Autschbach, Jutta Braunstein, Burkhard Helmke,
Volume 132, Issue 3, Pages (March 2007)
Volume 126, Issue 3, Pages (March 2004)
Volume 144, Issue 3, Pages e1 (March 2013)
Volume 136, Issue 2, Pages e5 (February 2009)
Volume 144, Issue 5, Pages e10 (May 2013)
Volume 129, Issue 1, Pages (July 2005)
Volume 133, Issue 5, Pages (November 2007)
Volume 143, Issue 5, Pages e1 (November 2012)
Volume 148, Issue 5, Pages e4 (May 2015)
Volume 141, Issue 6, Pages (December 2011)
Volume 136, Issue 4, Pages e3 (April 2009)
Volume 141, Issue 1, Pages e2 (July 2011)
Volume 132, Issue 1, Pages (January 2007)
Volume 124, Issue 5, Pages (May 2003)
Volume 133, Issue 6, Pages e14 (December 2007)
Volume 133, Issue 4, Pages (October 2007)
Growth Hormone Inhibits Signal Transducer and Activator of Transcription 3 Activation and Reduces Disease Activity in Murine Colitis  Xiaonan Han, Danuta.
Volume 143, Issue 4, Pages e9 (October 2012)
A Controlled Study of Colonic Immune Activity and β7+ Blood T Lymphocytes in Patients With Irritable Bowel Syndrome  Lena Öhman, Stefan Isaksson, Anna.
Volume 133, Issue 6, Pages (December 2007)
Volume 143, Issue 5, Pages e4 (November 2012)
Volume 132, Issue 1, Pages (January 2007)
Volume 134, Issue 4, Pages e2 (April 2008)
Volume 115, Issue 6, Pages (December 1998)
Volume 132, Issue 7, Pages (June 2007)
Volume 136, Issue 1, Pages e3 (January 2009)
Interleukin 15 mediates epithelial changes in celiac disease
Volume 140, Issue 1, Pages e2 (January 2011)
Characterization of Interleukin-17–Producing Regulatory T Cells in Inflamed Intestinal Mucosa From Patients With Inflammatory Bowel Diseases  Zaruhi Hovhannisyan,
Volume 124, Issue 5, Pages (May 2003)
Volume 128, Issue 5, Pages (May 2005)
Volume 132, Issue 1, Pages (January 2007)
Volume 140, Issue 1, Pages (January 2011)
Volume 141, Issue 3, Pages (September 2011)
Volume 119, Issue 6, Pages (December 2000)
Volume 140, Issue 4, Pages e1 (April 2011)
Volume 139, Issue 4, Pages e2 (October 2010)
Volume 141, Issue 5, Pages (November 2011)
Volume 137, Issue 5, Pages (November 2009)
Volume 135, Issue 6, Pages e7 (December 2008)
Volume 147, Issue 1, Pages (July 2014)
Volume 139, Issue 3, Pages e3 (September 2010)
Volume 141, Issue 1, Pages e1 (July 2011)
Volume 143, Issue 1, Pages (July 2012)
Volume 141, Issue 5, Pages e2 (November 2011)
Volume 131, Issue 5, Pages (November 2006)
Volume 138, Issue 2, Pages (February 2010)
Volume 144, Issue 3, Pages e1 (March 2013)
Volume 135, Issue 4, Pages e2 (October 2008)
Volume 132, Issue 1, Pages (January 2007)
Mechanisms of cross hyporesponsiveness to toll-like receptor bacterial ligands in intestinal epithelial cells  Jan-Michel Otte, Elke Cario, Daniel K.
Volume 132, Issue 4, Pages (April 2007)
Antigen-Presenting Cell Production of IL-10 Inhibits T-Helper 1 and 17 Cell Responses and Suppresses Colitis in Mice  Bo Liu, Susan L. Tonkonogy, R. Balfour.
Volume 135, Issue 2, Pages e2 (August 2008)
Volume 150, Issue 7, Pages (June 2016)
Volume 136, Issue 3, Pages (March 2009)
Volume 141, Issue 3, Pages (September 2011)
Volume 128, Issue 7, Pages (June 2005)
Volume 117, Issue 3, Pages (September 1999)
Volume 130, Issue 2, Pages (February 2006)
Volume 139, Issue 2, Pages (August 2010)
Volume 128, Issue 3, Pages (March 2005)
Volume 122, Issue 7, Pages (June 2002)
Volume 136, Issue 7, Pages (June 2009)
Volume 126, Issue 3, Pages (March 2004)
The human colonic monocarboxylate transporter Isoform 1: Its potential importance to colonic tissue homeostasis  Mark Cuff, Jane Dyer, Mark Jones, Soraya.
Volume 126, Issue 5, Pages (May 2004)
Presentation transcript:

Volume 134, Issue 1, Pages 179-191 (January 2008) A Prominent Role for Mucosal Cystine/Cysteine Metabolism in Intestinal Immunoregulation  Bernd Sido, Felix Lasitschka, Thomas Giese, Nikolaus Gassler, Benjamin Funke, Jutta Schröder–Braunstein, Ulf Brunnemer, Stefan C. Meuer, Frank Autschbach  Gastroenterology  Volume 134, Issue 1, Pages 179-191 (January 2008) DOI: 10.1053/j.gastro.2007.11.001 Copyright © 2008 AGA Institute Terms and Conditions

Figure 1 Total glutathione content in LP-T from normal gut mucosa vs autologous PB-T. Data are presented as means ± SD of 8 independent experiments. Gastroenterology 2008 134, 179-191DOI: (10.1053/j.gastro.2007.11.001) Copyright © 2008 AGA Institute Terms and Conditions

Figure 2 (A) Cysteine concentrations in the supernatants of LP-MO from normal gut vs autologous PB-MO after 40 hours of culture. Data represent means ± SD of 6 independent experiments. (B) Transmembrane transport activity for L-[35S]cystine (50 μmol/L) via system xc− in lamina propria cells from normal gut vs autologous peripheral blood cells. Specificity of system xc− was confirmed through inhibition of cystine uptake by L-glutamate. Results are presented as means ± SD of 6 independent experiments. (C) Representative Western blot analysis of xCT and β-actin in PB-MO vs LP-MO from normal gut mucosa. (D) Quantitative xCT and 4F2hc mRNA expression in LP-MO from normal gut vs autologous PB-MO. Values represent means ± SD of 3 independent experiments. Gastroenterology 2008 134, 179-191DOI: (10.1053/j.gastro.2007.11.001) Copyright © 2008 AGA Institute Terms and Conditions

Figure 3 In situ expression of the cystine transporter subunit xCT. (A) Immunoenzyme staining of xCT in normal colonic mucosa (NC) and inflamed colonic mucosa in UC and CD; NegC, negative control; original magnifications, ×30 for NC and NegC and ×60 for UC and CD. (B) Immunofluorescence staining of xCT in the normal colonic mucosa (NC) and inflamed ileum in CD. When compared with corresponding negative controls (NegC), some intestinal epithelia display weak positive stainings at their apical membrane (arrow). Gastroenterology 2008 134, 179-191DOI: (10.1053/j.gastro.2007.11.001) Copyright © 2008 AGA Institute Terms and Conditions

Figure 4 Phenotypic characterization of xCT+ cells in situ in IBD. Double immunofluorescence staining of xCT, red signals, and various cellular subtype-specific antigens, green signals, in the inflamed ileum in CD. Colocalization of both antigens is shown by yellow signals in the overlay (OL). Gastroenterology 2008 134, 179-191DOI: (10.1053/j.gastro.2007.11.001) Copyright © 2008 AGA Institute Terms and Conditions

Figure 5 (A) Quantitative expression of xCT mRNA in transmural gut samples (n = 101) of patients with UC and CD and normal controls. Transcript levels of xCT are significantly increased only in inflamed tissue in UC (n = 24) and CD (n = 29; 17 ileum, 12 colon) but not in noninflamed tissues in UC (n = 13) or CD (n = 18; 8 ileum, 10 colon) as compared with normal controls (n = 17; 9 colon, 8 ileum). Box plots (median, 25% and 75% percentile, minimum and maximum); *P ≤ .001 vs control. (B) Western blot analysis of xCT in mucosal isolates from patients with UC and CD and normal controls. Bracket indicates 2 samples derived from the same CD patient. (C) Cysteine secretion by LP-MO from inflamed colon in UC vs autologous PB-MO after 40 hours of culture with or without lipopolysaccharide (1 μg/mL). Data represent means ± SD of 6 independent experiments. (D) Thiol-dependent proliferation of isolated LP-T in UC following stimulation via CD3. Cultures were primarily set up in cystine-deficient medium and supplemented with either cysteine (30 μmol/L) or equimolar amounts of cystine (15 μmol/L) as described in the Materials and Methods section. Results are expressed as mean counts per minute of triplicate cultures ± SD and are representative of 3 independent experiments. Gastroenterology 2008 134, 179-191DOI: (10.1053/j.gastro.2007.11.001) Copyright © 2008 AGA Institute Terms and Conditions

Figure 6 (A) GSH staining of lamina propria cells in normal colonic mucosa (NC) and IBD. NegC, negative control. Alkaline phosphatase; magnifications, ×60. (B) Quantitative analysis of GSH expression in situ in IBD vs normal controls (Con) (total number, n = 57). The percentage of GSH-positive mucosal cells is significantly increased in inflamed areas in UC (n = 10) as well as colonic (n = 15) and ileal (n = 7) CD as compared with the respective colonic (n = 14) and ileal (n = 11) control samples. Box plots (median, 25% and 75% percentile, minimum and maximum); *P < .05, **P < .001 vs control. (C) Double immunofluorescence staining for GSH and CD3 in the inflamed colonic mucosa in UC. Most CD3+ cells stain positive for GSH, yellow signal in the overlay (OL). Gastroenterology 2008 134, 179-191DOI: (10.1053/j.gastro.2007.11.001) Copyright © 2008 AGA Institute Terms and Conditions

Figure 7 GSH levels in CD3+ LP-T from inflamed mucosa in IBD as compared with CD3+ LP-T from normal gut. LP-T and autologous PB-T isolated from a patient with active UC (A and B), or from a control patient (C and D), were double stained for CD3 and intracellular GSH and analyzed by flow cytometry. A representative example of GSH staining is shown as histograms. Data depict the percentage of CD3+ T cells being positive for GSH and the mean fluorescence intensity (MFI) of GSH staining. NegC, negative control. Gastroenterology 2008 134, 179-191DOI: (10.1053/j.gastro.2007.11.001) Copyright © 2008 AGA Institute Terms and Conditions

Figure 8 Quantitative gene expression analysis of the catalytic heavy subunit of γGCS in transmural gut samples (n = 101) of patients with UC and CD and normal controls. Transcript levels of γGCS are significantly decreased in inflamed tissue in UC (n = 24) and CD (n = 29; 17 ileum, 12 colon) but not in noninflamed tissue in UC (n = 13) or CD (n = 18; 8 ileum, 10 colon) as compared with normal controls (n = 17; 9 colon, 8 ileum). Box plots (median, 25% and 75% percentile, minimum and maximum); *P < .02, **P = .001 vs control. Gastroenterology 2008 134, 179-191DOI: (10.1053/j.gastro.2007.11.001) Copyright © 2008 AGA Institute Terms and Conditions